134 related articles for article (PubMed ID: 12740921)
1. Familial invasive and borderline ovarian tumors by proband status, age and histology.
Hemminki K; Granström C
Int J Cancer; 2003 Jul; 105(5):701-5. PubMed ID: 12740921
[TBL] [Abstract][Full Text] [Related]
2. Familial clustering of ovarian and endometrial cancers.
Hemminki K; Granström C
Eur J Cancer; 2004 Jan; 40(1):90-5. PubMed ID: 14687794
[TBL] [Abstract][Full Text] [Related]
3. Population attributable fractions for ovarian cancer in Swedish women by morphological type.
Granström C; Sundquist J; Hemminki K
Br J Cancer; 2008 Jan; 98(1):199-205. PubMed ID: 18071361
[TBL] [Abstract][Full Text] [Related]
4. Attributable risks for familial breast cancer by proband status and morphology: a nationwide epidemiologic study from Sweden.
Hemminki K; Granström C; Czene K
Int J Cancer; 2002 Jul; 100(2):214-9. PubMed ID: 12115572
[TBL] [Abstract][Full Text] [Related]
5. Familial breast carcinoma risks by morphology: a nationwide epidemiologic study from Sweden.
Hemminki K; Granström C
Cancer; 2002 Jun; 94(11):3063-70. PubMed ID: 12115398
[TBL] [Abstract][Full Text] [Related]
6. Familial association of specific histologic types of ovarian malignancy with other malignancies.
Lorenzo Bermejo J; Rawal R; Hemminki K
Cancer; 2004 Apr; 100(7):1507-14. PubMed ID: 15042686
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A
Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511
[TBL] [Abstract][Full Text] [Related]
8. Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden.
Hemminki K; Li X
Int J Cancer; 2003 Feb; 103(4):525-30. PubMed ID: 12478670
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of familial aggregation of ovarian and breast cancer in patients with ovarian cancer].
Ichikawa Y; Nishida M; Sugita M; Arisawa Y; Satoh T; Oki A; Kohno K; Shigemitsu S; Tsunoda H; Kubo T
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Sep; 47(9):901-6. PubMed ID: 7594899
[TBL] [Abstract][Full Text] [Related]
10. Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations.
Werness BA; Ramus SJ; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; Dicioccio RA; Tsukada Y; Ponder BA; Piver MS
Hum Pathol; 2000 Nov; 31(11):1420-4. PubMed ID: 11112219
[TBL] [Abstract][Full Text] [Related]
11. Second neoplasms after invasive and borderline ovarian cancer.
Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
[TBL] [Abstract][Full Text] [Related]
12. Incidence and mortality in epithelial ovarian cancer by family history of any cancer.
Hemminki K; Sundquist J; Brandt A
Cancer; 2011 Sep; 117(17):3972-80. PubMed ID: 21365633
[TBL] [Abstract][Full Text] [Related]
13. Familial risks of ovarian cancer by age at diagnosis, proband type and histology.
Zheng G; Yu H; Kanerva A; Försti A; Sundquist K; Hemminki K
PLoS One; 2018; 13(10):e0205000. PubMed ID: 30281663
[TBL] [Abstract][Full Text] [Related]
14. Familial risk of cancer by site and histopathology.
Hemminki K; Li X
Int J Cancer; 2003 Jan; 103(1):105-9. PubMed ID: 12455061
[TBL] [Abstract][Full Text] [Related]
15. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
Mayr D; Hirschmann A; Löhrs U; Diebold J
Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
17. Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma.
Hemminki K; Aaltonen L; Li X
Cancer; 2003 May; 97(10):2432-9. PubMed ID: 12733142
[TBL] [Abstract][Full Text] [Related]
18. Lactase persistence and ovarian carcinoma risk in Finland, Poland and Sweden.
Kuokkanen M; Butzow R; Rasinperä H; Medrek K; Nilbert M; Malander S; Lubinski J; Järvelä I
Int J Cancer; 2005 Oct; 117(1):90-4. PubMed ID: 15880573
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of hereditary ovarian cancer (HOC) in Poland.
Menkiszak J; Górski B; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Foszczyńska-Kłoda M; Fliciński J; Brzosko M; Rzepka-Górska I; Lubiński J
Ginekol Pol; 2002 Sep; 73(9):733-9. PubMed ID: 12602271
[TBL] [Abstract][Full Text] [Related]
20. Ovarian surface epithelial neoplasms in the pediatric population: incidence, histologic subtype, and natural history.
Hazard FK; Longacre TA
Am J Surg Pathol; 2013 Apr; 37(4):548-53. PubMed ID: 23388124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
